Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-03-05 @ 10:15 PM
Study NCT ID:
NCT02140333
Status:
UNKNOWN
Last Update Posted:
2015-02-12
First Post:
2013-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FAHG20130819
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None